2018年3月20日至21日第10届Ocular Diseases Drug Discovery Conference将在美国加州圣地牙哥举行。会期中，代表制药产业及学术界的研究人员将齐聚一堂，讨论不断改变眼科疾病治疗方式的技术及标靶。近年来为了找寻让药物更好地渗透前眼部与后眼部的方法，药物传输系统持续改善。另外，基因治疗与再生医学的成功也证明其不失为一种有趣的方法，在临床前研究与临床研究上需要深入探讨。本年度学会上主要研究人员与专家将齐聚一堂，讨论老年性黄斑病变 (AMD) 、乾眼症、青光眼、糖尿黄斑水肿 (DME) 等眼科疾病治疗方法，并建立新的合作关系。
- 开幕主题会议: 产业历史和现况
- 闭幕主题会议: 未来展望
|2018 ADVISORY BOARD MEMBERS|
|Matthias Birkhoff, Aptar|
|Oscar Cuzzani, BioTime|
|Emmett Cunningham, Clarus Ventures|
|Rafal Farjo, EyeCRO LLC|
|Rangaramujam Kannan, John Hopkins University|
Powered Research, LLC is a preclinical CRO that specializes in non-GLP swine, rabbit, and rodent models in the ophthalmic space. With our extensive expertise and quick turn-around time, we've helped multiple ocular companies with their R&D needs. In addition to in-life studies, we provide full bioanalytical and histology services in-house.
CBSET is a not-for-profit translational research institute specializing in the evaluation of drugs, biotherapeutics, combination products, and medical devices. We provide preclinical services including in-life testing, histopathology and regulatory consulting. Our GLP-compliant facilities host a multidisciplinary team of medical, scientific and regulatory experts who actively collaborate in getting novel technologies to market.
Viracor Eurofins provides clinical trial biomarker testing services with expertise in custom assay transfer, design and validation for phase I-IV trials. Our CAP/CLIA and NY state accredited laboratory has over 30 years of experience in molecular testing, immune response monitoring, vaccine safety/efficacy assessment, allergy and hypersensitivity testing.
Cancer Genetics Inc. (CGI; Nasdaq: CGIX) is a leader in enabling precision medicine in oncology from bench to bedside through the use of oncology biomarkers and molecular testing. CGI is developing a global footprint with locations in the US, India and China. The Company offers a comprehensive range of laboratory services that provide critical genomic and biomarker information. Its state-of-the-art reference labs are CLIA-certified and CAP-accredited in the US and have licensure from several states including New York State. CGI has established strong clinical research collaborations with major cancer centers such as Memorial Sloan Kettering, The Cleveland Clinic, Mayo Clinic, Keck School of Medicine at USC and the National Cancer Institute.